Literature DB >> 28391069

Insulin and glucagon in plasma and cerebrospinal fluid in suicide attempters and healthy controls.

Marie Bendix1, Kerstin Uvnäs-Moberg2, Maria Petersson3, Viktor Kaldo4, Marie Åsberg5, Jussi Jokinen6.   

Abstract

Mental disorders and related behaviors such as suicidality and violence have been associated to dysregulation of e g carbohydrate metabolism. We hypothesized that patients after suicide attempt, compared to healthy controls, would have higher insulin and lower glucagon levels in plasma and cerebrospinal fluid and that these changes would be associated to violent behavior. Twenty-eight medication-free patients (10 women, 18 men), hospitalized after suicide attempt, and 19 healthy controls (7 women, 12 men) were recruited with the aim to study risk factors for suicidal behavior. Psychological/psychiatric assessment was performed with SCID I and II or the SCID interview for healthy volunteers respectively, the Karolinska Interpersonal Violence Scale (KIVS) for assessment of lifetime violence expression behavior, the Montgomery-Åsberg-Depression-Scale (MADRS) and the Comprehensive Psychological Rating Scale (CPRS) for symptomatic assessment of depression and appetite. Fasting levels of insulin and glucagon were measured in plasma (P) and cerebrospinal fluid (CSF). Suicide attempters had higher insulin- and lower glucagon-levels in plasma- and CSF compared to controls. Except for P-glucagon these associations remained significant after adjusting for age and/or BMI. Patients reported significantly more expressed interpersonal violence compared to healthy volunteers. Expressed violence was significantly positively correlated with P- and CSF-insulin and showed a significant negative correlation with P-glucagon in study participants. These findings confirm and extend prior reports that higher insulin and lower glucagon levels in plasma and cerebrospinal fluid are associated with suicidal behavior pointing towards a potential autonomic dysregulation in the control of insulin and glucagon secretion in suicidal patients.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aggression; Depression; Glucagon; Insulin; Suicide attempt; Violence

Mesh:

Substances:

Year:  2017        PMID: 28391069     DOI: 10.1016/j.psyneuen.2017.03.019

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  5 in total

1.  Adolescent Suicide as a Failure of Acute Stress-Response Systems.

Authors:  Adam Bryant Miller; Mitchell J Prinstein
Journal:  Annu Rev Clin Psychol       Date:  2019-02-20       Impact factor: 18.561

2.  Risk Factors and Prevalence of Suicide Attempt in Patients with Type 2 Diabetes in the Mexican Population.

Authors:  Tania Guadalupe Gómez-Peralta; Thelma Beatriz González-Castro; Ana Fresan; Carlos Alfonso Tovilla-Zárate; Isela Esther Juárez-Rojop; Mario Villar-Soto; Yazmín Hernández-Díaz; María Lilia López-Narváez; Jorge L Ble-Castillo; Nonanzit Pérez-Hernández; José Manuel Rodríguez-Pérez
Journal:  Int J Environ Res Public Health       Date:  2018-06-07       Impact factor: 3.390

3.  Cues for different diagnostic patterns of interpersonal violence in a psychiatric sample: an observational study.

Authors:  Dalila Talevi; Alberto Collazzoni; Alessandro Rossi; Paolo Stratta; Monica Mazza; Francesca Pacitti; Manuela Costa; Claudio Crescini; Rodolfo Rossi
Journal:  BMC Psychiatry       Date:  2020-05-01       Impact factor: 3.630

Review 4.  Catalytic Reaction Model of Suicide.

Authors:  Pamela McPherson; Saveen Sall; Aurianna Santos; Willie Thompson; Donard S Dwyer
Journal:  Front Psychiatry       Date:  2022-03-09       Impact factor: 4.157

5.  Integrating Metabolomics and Network Analysis for Exploring the Mechanism Underlying the Antidepressant Activity of Paeoniflorin in Rats With CUMS-Induced Depression.

Authors:  Chaofang Lei; Zhigang Chen; Lili Fan; Zhe Xue; Jianbei Chen; Xihong Wang; Zhen Huang; Yinian Men; Mingzhi Yu; Yueyun Liu; Jiaxu Chen
Journal:  Front Pharmacol       Date:  2022-06-13       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.